Dr. Craig Hofmeister's T-cell therapy project garnered some well earned attention this week. Dr. Hofmeister's Ohio State University research team is one of several working on ways to use T-cells to fight cancer. And fortunately for us, much of the work centers on multiple myeloma. Here's an article that ran in Monday's Science World Report:
Innovative myeloma research and care is alive and well in the State of Ohio! Led by high profile myeloma specialist, Dr. Craig Hofmeister, something called the Ohio Myeloma Initiative is gaining momentum, becoming a model others in the myeloma community should emulate. The Ohio Myeloma Initiative is an effort to create an online resource and
Today seemed like a good day to catch up on some important myeloma related topics. Anthony, a fellow support group leader from California, sent me this article he found in Today's Caregiver (Caregiver.com). Here's an excerpt: Understanding the Risk of Infection During Chemotherapy What is Nadir? Chemotherapy treatment will usually involve a number of chemotherapy
Yesterday's post focused on why some patient's immune systems fight off multiple myeloma better than others. Later in the day I hosted an on-air support group meeting featuring special guest, myeloma specialist Dr. Craig Hofmeister. He spent much of the hour discussing immunotherapy--his specialty. Here's a link to the broadcast: http://www.blogtalkradio.com/curepanel/2013/10/29/myeloma-survival-data-w-dr-hofmeister-james-cancer-center Immunotherapy is a hot
The American Society of Hematology (ASH) annual meeting is just around the corner. The world's biggest and most important gathering of myeloma researchers and clinicians meets December 6th-10th in New Orleans. I will be there covering the event, courtesy of the International Myeloma Foundation (IMF). I'm excited to be returning to New Orleans, the site
Dana-Farber's Dr. Paul Richardson will be the featured guest on Thursday night's Myeloma Cure Panel broadcast. And Ohio State's myeloma expert, Dr. Craig Hofmeister, will be joining us for our on-air multiple myeloma support group meeting next Tuesday. Click on the link below for the phone number to listen live via phone or on your
One of Andrew Schorr's better clips featuring Dr. Craig Hofmeister, Ohio State University Comprehensive Cancer Center, and Dr. Sagar Lonial, Winship Cancer Institute of Emory University, discussing different myeloma therapies including stem cell transplants, non-transplants, targeted and combination therapies: Transplant or Targeted Therapy: What's the Mainstay for Treatment in Multiple Myeloma?